HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 20-JAN-14 4OIM TITLE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS INHA IN COMPLEX WITH TITLE 2 INHIBITOR PT119 IN 2.4 M ACETATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: INHA, RV1484, MT1531, MTCY277.05; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET-15B KEYWDS INHIBITION, HIGH-CONCENTRATION ACETATE, SLOW-ONSET INHIBITION, KEYWDS 2 SUBSTRATE BINDING LOOP CONFORMATIONAL HETEROGENEITY, OXIDOREDUCTASE- KEYWDS 3 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.J.LI,P.PAN,C.T.LAI,N.LIU,M.GARCIA-DIAZ,C.SIMMERLING,P.J.TONGE REVDAT 3 20-SEP-23 4OIM 1 REMARK SEQADV REVDAT 2 22-NOV-17 4OIM 1 REMARK REVDAT 1 23-APR-14 4OIM 0 JRNL AUTH P.PAN,S.E.KNUDSON,G.R.BOMMINENI,H.J.LI,C.T.LAI,N.LIU, JRNL AUTH 2 M.GARCIA-DIAZ,C.SIMMERLING,S.S.PATIL,R.A.SLAYDEN,P.J.TONGE JRNL TITL TIME-DEPENDENT DIARYL ETHER INHIBITORS OF INHA: JRNL TITL 2 STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF ENZYME JRNL TITL 3 INHIBITION, ANTIBACTERIAL ACTIVITY, AND IN VIVO EFFICACY. JRNL REF CHEMMEDCHEM V. 9 776 2014 JRNL REFN ISSN 1860-7179 JRNL PMID 24616444 JRNL DOI 10.1002/CMDC.201300429 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.J.LI,C.T.LAI,P.PAN,W.YU,N.LIU,M.GARCIA-DIAZ,C.SIMMERLING, REMARK 1 AUTH 2 P.J.TONGE REMARK 1 TITL A STRUCTURAL AND ENERGETIC MODEL FOR THE SLOW-ONSET REMARK 1 TITL 2 INHIBITION OF INHA, AN ENZYME DRUG TARGET FROM MYCOBACTERIUM REMARK 1 TITL 3 TUBERCULOSIS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.2_869 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.31 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 32823 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1633 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.3246 - 4.2290 0.98 2755 149 0.1700 0.1827 REMARK 3 2 4.2290 - 3.3571 1.00 2671 125 0.1615 0.2001 REMARK 3 3 3.3571 - 2.9328 1.00 2651 111 0.1739 0.2242 REMARK 3 4 2.9328 - 2.6647 1.00 2608 142 0.1837 0.1978 REMARK 3 5 2.6647 - 2.4737 1.00 2595 148 0.1791 0.2219 REMARK 3 6 2.4737 - 2.3279 1.00 2587 126 0.1645 0.1923 REMARK 3 7 2.3279 - 2.2113 1.00 2582 148 0.1589 0.1775 REMARK 3 8 2.2113 - 2.1150 1.00 2581 147 0.1503 0.1866 REMARK 3 9 2.1150 - 2.0336 1.00 2569 140 0.1651 0.1929 REMARK 3 10 2.0336 - 1.9634 1.00 2589 121 0.1749 0.1964 REMARK 3 11 1.9634 - 1.9020 1.00 2561 144 0.1876 0.2098 REMARK 3 12 1.9020 - 1.8477 0.96 2441 132 0.2132 0.2556 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 43.61 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.51620 REMARK 3 B22 (A**2) : 3.51620 REMARK 3 B33 (A**2) : -7.03240 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2214 REMARK 3 ANGLE : 1.143 3017 REMARK 3 CHIRALITY : 0.071 338 REMARK 3 PLANARITY : 0.006 381 REMARK 3 DIHEDRAL : 14.240 801 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 0.6033 -21.2614 5.6890 REMARK 3 T TENSOR REMARK 3 T11: 0.5016 T22: 0.1302 REMARK 3 T33: 0.2608 T12: 0.0017 REMARK 3 T13: -0.0646 T23: 0.0376 REMARK 3 L TENSOR REMARK 3 L11: 1.6589 L22: 1.3739 REMARK 3 L33: 2.6844 L12: -0.1914 REMARK 3 L13: 0.0328 L23: -0.1332 REMARK 3 S TENSOR REMARK 3 S11: 0.0981 S12: -0.1699 S13: -0.3382 REMARK 3 S21: 0.1569 S22: 0.0554 S23: 0.0109 REMARK 3 S31: 0.9478 S32: 0.0319 S33: -0.1237 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OIM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084539. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : DOUBLE SILICON(111) CRYSTAL REMARK 200 SAGITTAL FOCUSING REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32854 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 0.68000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2X23 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4 M SODIUM ACETATE, PH 5.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 45.31100 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 91.31700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 45.65850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.31100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 136.97550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 136.97550 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.31100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.65850 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 45.31100 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 91.31700 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 45.31100 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 91.31700 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 45.31100 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 136.97550 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 45.65850 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 45.31100 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 45.65850 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 136.97550 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 45.31100 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 45.31100 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 91.31700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 27110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -158.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 418 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 2 N CA CB OG1 CG2 REMARK 470 ASP A 6 CG OD1 OD2 REMARK 470 ASP A 18 CG OD1 OD2 REMARK 470 GLN A 35 CG CD OE1 NE2 REMARK 470 LEU A 46 CD1 CD2 REMARK 470 ARG A 53 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 GLU A 68 CG CD OE1 OE2 REMARK 470 GLU A 69 CG CD OE1 OE2 REMARK 470 GLN A 100 CG CD OE1 NE2 REMARK 470 ILE A 105 CD1 REMARK 470 LYS A 118 CE NZ REMARK 470 ARG A 195 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 207 CG CD1 CD2 REMARK 470 GLU A 210 CG CD OE1 OE2 REMARK 470 GLN A 216 CG CD OE1 NE2 REMARK 470 LEU A 217 CG CD1 CD2 REMARK 470 GLU A 220 CG CD OE1 OE2 REMARK 470 GLN A 224 CG CD OE1 NE2 REMARK 470 LYS A 233 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 16 -36.02 -133.81 REMARK 500 ASP A 42 -65.75 75.55 REMARK 500 ARG A 43 70.08 -108.45 REMARK 500 ALA A 124 -57.71 -125.21 REMARK 500 ALA A 157 -39.97 73.33 REMARK 500 ASN A 159 -117.94 42.40 REMARK 500 LEU A 207 87.21 -63.17 REMARK 500 ALA A 260 76.57 -102.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JUS A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 311 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 313 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OHU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS INHA IN COMPLEX REMARK 900 WITH INHIBITOR PT92 DBREF 4OIM A 1 269 UNP P0A5Y6 INHA_MYCTU 1 269 SEQADV 4OIM MET A -19 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM GLY A -18 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM SER A -17 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM SER A -16 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -15 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -14 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -13 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -12 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -11 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A -10 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM SER A -9 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM SER A -8 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM GLY A -7 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM LEU A -6 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM VAL A -5 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM PRO A -4 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM ARG A -3 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM GLY A -2 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM SER A -1 UNP P0A5Y6 EXPRESSION TAG SEQADV 4OIM HIS A 0 UNP P0A5Y6 EXPRESSION TAG SEQRES 1 A 289 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 289 LEU VAL PRO ARG GLY SER HIS MET THR GLY LEU LEU ASP SEQRES 3 A 289 GLY LYS ARG ILE LEU VAL SER GLY ILE ILE THR ASP SER SEQRES 4 A 289 SER ILE ALA PHE HIS ILE ALA ARG VAL ALA GLN GLU GLN SEQRES 5 A 289 GLY ALA GLN LEU VAL LEU THR GLY PHE ASP ARG LEU ARG SEQRES 6 A 289 LEU ILE GLN ARG ILE THR ASP ARG LEU PRO ALA LYS ALA SEQRES 7 A 289 PRO LEU LEU GLU LEU ASP VAL GLN ASN GLU GLU HIS LEU SEQRES 8 A 289 ALA SER LEU ALA GLY ARG VAL THR GLU ALA ILE GLY ALA SEQRES 9 A 289 GLY ASN LYS LEU ASP GLY VAL VAL HIS SER ILE GLY PHE SEQRES 10 A 289 MET PRO GLN THR GLY MET GLY ILE ASN PRO PHE PHE ASP SEQRES 11 A 289 ALA PRO TYR ALA ASP VAL SER LYS GLY ILE HIS ILE SER SEQRES 12 A 289 ALA TYR SER TYR ALA SER MET ALA LYS ALA LEU LEU PRO SEQRES 13 A 289 ILE MET ASN PRO GLY GLY SER ILE VAL GLY MET ASP PHE SEQRES 14 A 289 ASP PRO SER ARG ALA MET PRO ALA TYR ASN TRP MET THR SEQRES 15 A 289 VAL ALA LYS SER ALA LEU GLU SER VAL ASN ARG PHE VAL SEQRES 16 A 289 ALA ARG GLU ALA GLY LYS TYR GLY VAL ARG SER ASN LEU SEQRES 17 A 289 VAL ALA ALA GLY PRO ILE ARG THR LEU ALA MET SER ALA SEQRES 18 A 289 ILE VAL GLY GLY ALA LEU GLY GLU GLU ALA GLY ALA GLN SEQRES 19 A 289 ILE GLN LEU LEU GLU GLU GLY TRP ASP GLN ARG ALA PRO SEQRES 20 A 289 ILE GLY TRP ASN MET LYS ASP ALA THR PRO VAL ALA LYS SEQRES 21 A 289 THR VAL CYS ALA LEU LEU SER ASP TRP LEU PRO ALA THR SEQRES 22 A 289 THR GLY ASP ILE ILE TYR ALA ASP GLY GLY ALA HIS THR SEQRES 23 A 289 GLN LEU LEU HET NAD A 301 44 HET JUS A 302 22 HET ACT A 303 4 HET ACT A 304 4 HET ACT A 305 4 HET ACT A 306 4 HET ACT A 307 4 HET ACT A 308 4 HET ACT A 309 4 HET ACT A 310 4 HET ACT A 311 4 HET ACT A 312 4 HET ACT A 313 4 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM JUS 2-(2-CYANOPHENOXY)-5-HEXYLPHENOL HETNAM ACT ACETATE ION FORMUL 2 NAD C21 H27 N7 O14 P2 FORMUL 3 JUS C19 H21 N O2 FORMUL 4 ACT 11(C2 H3 O2 1-) FORMUL 15 HOH *75(H2 O) HELIX 1 1 SER A 20 GLN A 32 1 13 HELIX 2 2 ARG A 43 ASP A 52 1 10 HELIX 3 3 ASN A 67 GLY A 83 1 17 HELIX 4 4 PRO A 99 MET A 103 5 5 HELIX 5 5 PRO A 107 ALA A 111 5 5 HELIX 6 6 PRO A 112 ALA A 124 1 13 HELIX 7 7 ALA A 124 LEU A 135 1 12 HELIX 8 8 TYR A 158 GLY A 180 1 23 HELIX 9 9 LYS A 181 GLY A 183 5 3 HELIX 10 10 THR A 196 LEU A 207 1 12 HELIX 11 11 GLU A 209 ALA A 226 1 18 HELIX 12 12 ALA A 235 SER A 247 1 13 HELIX 13 13 GLY A 263 GLN A 267 5 5 SHEET 1 A 7 LEU A 60 GLU A 62 0 SHEET 2 A 7 GLN A 35 GLY A 40 1 N LEU A 38 O LEU A 61 SHEET 3 A 7 ARG A 9 SER A 13 1 N VAL A 12 O VAL A 37 SHEET 4 A 7 LEU A 88 HIS A 93 1 O ASP A 89 N ARG A 9 SHEET 5 A 7 MET A 138 ASP A 148 1 O VAL A 145 N HIS A 93 SHEET 6 A 7 ARG A 185 ALA A 191 1 O VAL A 189 N ASP A 148 SHEET 7 A 7 ASP A 256 ALA A 260 1 O ILE A 258 N LEU A 188 SITE 1 AC1 31 GLY A 14 ILE A 15 ILE A 16 SER A 20 SITE 2 AC1 31 ILE A 21 PHE A 41 LEU A 63 ASP A 64 SITE 3 AC1 31 VAL A 65 SER A 94 ILE A 95 GLY A 96 SITE 4 AC1 31 ILE A 122 MET A 147 ASP A 148 LYS A 165 SITE 5 AC1 31 ALA A 191 GLY A 192 PRO A 193 ILE A 194 SITE 6 AC1 31 THR A 196 LEU A 197 ALA A 198 JUS A 302 SITE 7 AC1 31 ACT A 303 HOH A 413 HOH A 423 HOH A 428 SITE 8 AC1 31 HOH A 433 HOH A 435 HOH A 461 SITE 1 AC2 12 GLY A 96 PHE A 97 MET A 103 PRO A 156 SITE 2 AC2 12 TYR A 158 MET A 161 LYS A 165 ALA A 198 SITE 3 AC2 12 MET A 199 ILE A 202 NAD A 301 ACT A 304 SITE 1 AC3 5 PHE A 41 GLN A 66 PHE A 97 ILE A 122 SITE 2 AC3 5 NAD A 301 SITE 1 AC4 5 PHE A 97 MET A 98 MET A 103 ALA A 201 SITE 2 AC4 5 JUS A 302 SITE 1 AC5 5 ARG A 43 ALA A 206 GLY A 208 GLY A 212 SITE 2 AC5 5 ALA A 213 SITE 1 AC6 5 SER A 19 HIS A 24 ILE A 194 LYS A 233 SITE 2 AC6 5 ALA A 235 SITE 1 AC7 4 ARG A 9 ASN A 86 LYS A 87 ASN A 139 SITE 1 AC8 1 LYS A 181 SITE 1 AC9 2 ARG A 77 ACT A 310 SITE 1 BC1 4 LEU A 61 GLU A 62 ARG A 77 ACT A 309 SITE 1 BC2 3 LYS A 181 TYR A 182 GLY A 183 SITE 1 BC3 4 ILE A 228 GLY A 229 TRP A 230 ACT A 313 SITE 1 BC4 3 ASP A 223 TRP A 230 ACT A 312 CRYST1 90.622 90.622 182.634 90.00 90.00 90.00 I 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011035 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005475 0.00000